Hu Xinjun, Yin Bingyou, Liu Ruishan, Gong Lu, Yang Xiaolu, Lou Zhenghao, Ye Haowei, Shang Bingyang, Shang Yibing, Zhang Yingjian
Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China.
Henan Medical Key Laboratory of Gastrointestinal Microecology and Hepatology, Luoyang, China.
Sci Rep. 2025 May 31;15(1):19132. doi: 10.1038/s41598-025-03759-1.
The coexistence of multiple resistance genes within a single bacterial strain presents a significant public health challenge, as it complicates treatment options and accelerates the spread of multidrug resistance. While the co-occurrence of bla and mcr-1 genes in Klebsiella pneumoniae (KP) is uncommon, this study reports the biological characterization of a K. pneumoniae isolate, L5151, derived from a patient with diarrhea. This strain carries bla, mcr-1, and bla resistance genes simultaneously. Multilocus sequence typing (MLST) analysis identified the L5151 strain as an ST499 type. Antimicrobial susceptibility testing (AST) was conducted via agar dilution and the broth microdilution procedure. The AST results revealed that L5151 is resistant to a variety of antibiotics. Whole-genome sequencing (WGS) and bioinformatics analysis were performed to determine the genetic composition of the strain, including the presence and characteristics of resistance genes. The results of S1 nuclease-pulsed field gel electrophoresis (S1-PFGE) and Southern blotting confirmed that the L5151 strain harbors three plasmids and that the plasmid carrying mcr-1 (pL5151_MCR_CTX) is of the IncI2(Delta) type, whereas the plasmid carrying bla (pL5151_NDM) is of the IncN type. The combination of these plasmids in recipient strains conferred enhanced resistance to carbapenems and colistin, highlighting the potential for increased treatment challenges. This study emphasizes the importance of ongoing surveillance of multidrug-resistant strains to prevent their spread and outbreaks. These findings provide critical insights for clinical treatment strategies and infection prevention and control measures. Enhanced surveillance and targeted interventions are essential to manage the public health risks posed by multidrug-resistant strains.
单个细菌菌株中存在多个耐药基因对公共卫生构成了重大挑战,因为这使治疗选择变得复杂,并加速了多重耐药性的传播。虽然肺炎克雷伯菌(KP)中bla和mcr-1基因同时出现的情况并不常见,但本研究报告了一株从腹泻患者分离出的肺炎克雷伯菌L5151的生物学特征。该菌株同时携带bla、mcr-1和bla耐药基因。多位点序列分型(MLST)分析确定L5151菌株为ST499型。通过琼脂稀释法和肉汤微量稀释法进行了药敏试验(AST)。AST结果显示L5151对多种抗生素耐药。进行了全基因组测序(WGS)和生物信息学分析以确定该菌株的基因组成,包括耐药基因的存在和特征。S1核酸酶脉冲场凝胶电泳(S1-PFGE)和Southern印迹结果证实L5151菌株含有三个质粒,携带mcr-1的质粒(pL5151_MCR_CTX)为IncI2(Delta)型,而携带bla的质粒(pL5151_NDM)为IncN型。这些质粒在受体菌株中的组合赋予了对碳青霉烯类和黏菌素更强的耐药性,突出了治疗挑战增加的可能性。本研究强调了持续监测多重耐药菌株以防止其传播和暴发的重要性。这些发现为临床治疗策略以及感染预防和控制措施提供了关键见解。加强监测和有针对性的干预对于应对多重耐药菌株带来的公共卫生风险至关重要。